Scopoletin induces apoptosis in human promyeloleukemic cells, accompanied by activations of nuclear factor kappaB and caspase-3. 2005

Eun-Kyung Kim, and Kang-Beom Kwon, and Byung-Cheul Shin, and Eun-A Seo, and Young-Rae Lee, and Jong-Suk Kim, and Jin-Woo Park, and Byung-Hyun Park, and Do-Gon Ryu
Department of Physiology, School of Oriental Medicine, Wonkwang University, Iksan, Chonbuk 570-749, South Korea.

Scopoletin (6-methoxy-7-hydroxycoumarin) is a phenolic coumarin and a member of the phytoalexins. In this study we investigated whether scopoletin caused apoptosis in HL-60 promyelocytic cells and, if so, by what mechanisms. We found that scopoletin induced apoptosis as confirmed by a characteristic ladder pattern of discontinuous DNA fragments in a dose-dependent manner. The signal cascade activated by scopoletin included the heterodimeric redox-sensitive transcription factor NF-kappaB, which exhibited an upregulation of nuclear factor-kappa B (NF-kappaB) translocation to the nucleus by increase of IkappaBalpha degradation. In addition, scopoletin activated caspase-3 as was evidenced by both the proteolytic cleavage of the proenzyme and increased protease activity. Activation of caspase-3 resulted in the cleavage of 116 kDa poly(ADP-ribose) polymerase (PARP) to 85 kDa cleavage product in time-and dose-dependent fashions. Prior treatment of the cells with pyrrolidine dithiocarbamate, a potent inhibitor of NF-kappaB activation, or Ac-DEVD-CHO, a specific caspase-3 inhibitor, prevented scopoletin-induced caspase-3 activation, PARP cleavage, and finally DNA fragmentation. Taken together, these results suggest that scopoletin induces NF-kappaB activation, which, in turn, causes activation of caspase-3, degradation of PARP, and eventually leads to apoptotic cell death in HL-60 cells.

UI MeSH Term Description Entries
D011065 Poly(ADP-ribose) Polymerases Enzymes that catalyze the transfer of multiple ADP-RIBOSE groups from nicotinamide-adenine dinucleotide (NAD) onto protein targets, thus building up a linear or branched homopolymer of repeating ADP-ribose units i.e., POLY ADENOSINE DIPHOSPHATE RIBOSE. ADP-Ribosyltransferase (Polymerizing),Poly ADP Ribose Polymerase,Poly(ADP-Ribose) Synthase,Poly(ADP-ribose) Polymerase,PARP Polymerase,Poly ADP Ribose Transferase,Poly ADP-Ribose Synthase,Poly(ADP-Ribose) Transferase,Poly(ADPR) Polymerase,Poly(ADPribose) Polymerase,Poly ADP Ribose Synthase,Polymerase, PARP,Synthase, Poly ADP-Ribose
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004587 Electrophoresis, Agar Gel Electrophoresis in which agar or agarose gel is used as the diffusion medium. Electrophoresis, Agarose Gel,Agar Gel Electrophoresis,Agarose Gel Electrophoresis,Gel Electrophoresis, Agar,Gel Electrophoresis, Agarose
D004789 Enzyme Activation Conversion of an inactive form of an enzyme to one possessing metabolic activity. It includes 1, activation by ions (activators); 2, activation by cofactors (coenzymes); and 3, conversion of an enzyme precursor (proenzyme or zymogen) to an active enzyme. Activation, Enzyme,Activations, Enzyme,Enzyme Activations
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000072000 NF-KappaB Inhibitor alpha An I-kappa B protein that inhibits the activity of dimeric NF-KAPPA B P50-REL complexes, sequesters transcription factor NF-kappaB as an inactive complex in the cytoplasm; and prevents NF-kappaB nuclear translocation and DNA binding. I Kappa B-alpha Protein,IKappaB-alpha,IKappaBalpha,Major Histocompatibility Complex Enhancer-Binding Protein MAD3,p40 Protein (IKappaB-alpha),I Kappa B alpha Protein,IKappaB alpha,Inhibitor alpha, NF-KappaB,Major Histocompatibility Complex Enhancer Binding Protein MAD3,NF KappaB Inhibitor alpha,alpha, NF-KappaB Inhibitor
D000704 Analysis of Variance A statistical technique that isolates and assesses the contributions of categorical independent variables to variation in the mean of a continuous dependent variable. ANOVA,Analysis, Variance,Variance Analysis,Analyses, Variance,Variance Analyses
D012603 Scopoletin Plant growth factor derived from the root of Scopolia carniolica or Scopolia japonica. Chrysotropic Acid,Gelseminic Acid,Methylesculetin,Acid, Chrysotropic,Acid, Gelseminic
D013778 Tetrazolium Salts Quaternary salts derived from tetrazoles. They are used in tests to distinguish between reducing sugars and simple aldehydes, for detection of dehydrogenase in tissues, cells, and bacteria, for determination of corticosteroids, and in color photography. (From Mall's Dictionary of Chemistry, 5th ed, p455) Tetrazolium Salt,Salt, Tetrazolium,Salts, Tetrazolium
D013844 Thiazoles Heterocyclic compounds where the ring system is composed of three CARBON atoms, a SULFUR and NITROGEN atoms. Thiazole

Related Publications

Eun-Kyung Kim, and Kang-Beom Kwon, and Byung-Cheul Shin, and Eun-A Seo, and Young-Rae Lee, and Jong-Suk Kim, and Jin-Woo Park, and Byung-Hyun Park, and Do-Gon Ryu
March 1998, Molecular pharmacology,
Eun-Kyung Kim, and Kang-Beom Kwon, and Byung-Cheul Shin, and Eun-A Seo, and Young-Rae Lee, and Jong-Suk Kim, and Jin-Woo Park, and Byung-Hyun Park, and Do-Gon Ryu
December 2002, Biochemical pharmacology,
Eun-Kyung Kim, and Kang-Beom Kwon, and Byung-Cheul Shin, and Eun-A Seo, and Young-Rae Lee, and Jong-Suk Kim, and Jin-Woo Park, and Byung-Hyun Park, and Do-Gon Ryu
January 2006, Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology,
Eun-Kyung Kim, and Kang-Beom Kwon, and Byung-Cheul Shin, and Eun-A Seo, and Young-Rae Lee, and Jong-Suk Kim, and Jin-Woo Park, and Byung-Hyun Park, and Do-Gon Ryu
September 2003, Molecular endocrinology (Baltimore, Md.),
Eun-Kyung Kim, and Kang-Beom Kwon, and Byung-Cheul Shin, and Eun-A Seo, and Young-Rae Lee, and Jong-Suk Kim, and Jin-Woo Park, and Byung-Hyun Park, and Do-Gon Ryu
January 2002, Biochemical pharmacology,
Eun-Kyung Kim, and Kang-Beom Kwon, and Byung-Cheul Shin, and Eun-A Seo, and Young-Rae Lee, and Jong-Suk Kim, and Jin-Woo Park, and Byung-Hyun Park, and Do-Gon Ryu
February 2001, Circulation research,
Eun-Kyung Kim, and Kang-Beom Kwon, and Byung-Cheul Shin, and Eun-A Seo, and Young-Rae Lee, and Jong-Suk Kim, and Jin-Woo Park, and Byung-Hyun Park, and Do-Gon Ryu
December 2001, Journal of neuroscience research,
Eun-Kyung Kim, and Kang-Beom Kwon, and Byung-Cheul Shin, and Eun-A Seo, and Young-Rae Lee, and Jong-Suk Kim, and Jin-Woo Park, and Byung-Hyun Park, and Do-Gon Ryu
January 2005, American journal of hematology,
Eun-Kyung Kim, and Kang-Beom Kwon, and Byung-Cheul Shin, and Eun-A Seo, and Young-Rae Lee, and Jong-Suk Kim, and Jin-Woo Park, and Byung-Hyun Park, and Do-Gon Ryu
October 2005, Molecular cancer therapeutics,
Eun-Kyung Kim, and Kang-Beom Kwon, and Byung-Cheul Shin, and Eun-A Seo, and Young-Rae Lee, and Jong-Suk Kim, and Jin-Woo Park, and Byung-Hyun Park, and Do-Gon Ryu
December 2009, Acta pharmacologica Sinica,
Copied contents to your clipboard!